Part B Coding Coach: Tackle the Top-3 ICD-9 Oncology Changes Before the Oct. 1 Deadline Hits

Why This Topic Matters

These changes can affect claim accuracy, documentation requirements, and coder-provider communication. The article helps readers identify which oncology topics are changing and what operational steps to consider before the transition date.

Article Sections

1. Blast Out of Your 202.80 Rut in 2008

   Reviews upcoming ICD-9 lymphoma updates and the documentation changes needed to support more specific reporting. It also discusses the general need to coordinate provider documentation with the expanded code structure.

2. Follow This Map to New Malignant Ascites Code

   Covers the addition of new ascites-related ICD-9 reporting options and the general distinction between malignant and other ascites. It also notes the importance of updating internal resources and software.

3. Watch for Answer to Your Tamoxifen Question

   Summarizes a proposed ICD-9 issue involving antiestrogen prophylactic administration and long-term drug use guidance. It highlights that the topic relates to Tamoxifen reporting and future clarification of cancer status coding.